These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12666260)

  • 21. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic advances in acute ischaemic stroke.
    Bhalla A; Rudd AG
    Int J Clin Pract; 1999 Jun; 53(4):295-300. PubMed ID: 10563075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,026 experimental treatments in acute stroke.
    O'Collins VE; Macleod MR; Donnan GA; Horky LL; van der Worp BH; Howells DW
    Ann Neurol; 2006 Mar; 59(3):467-77. PubMed ID: 16453316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection for ischaemic stroke: current status and challenges.
    Moretti A; Ferrari F; Villa RF
    Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotection and stroke: time for a compromise.
    Young AR; Ali C; Duretête A; Vivien D
    J Neurochem; 2007 Nov; 103(4):1302-9. PubMed ID: 17727635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Overview of the recent clinical trials in severe head injury and analysis of their therapeutic failure].
    Boto GR; Gómez PA; De la Cruz J; Lobato RD
    Neurocirugia (Astur); 2005 Feb; 16(1):39-49. PubMed ID: 15756410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y; Marumo T; Omura T; Yoshida S
    Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection in acute ischemic stroke.
    De Keyser J; Uyttenboogaart M; Koch MW; Elting JW; Sulter G; Vroomen PC; Luijckx GJ
    Acta Neurol Belg; 2005 Sep; 105(3):144-8. PubMed ID: 16255152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection in stroke.
    Khurana D; Bal S
    J Indian Med Assoc; 2009 Jun; 107(6):378-82, 391. PubMed ID: 19886376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic strategies for the treatment of stroke.
    Green AR; Shuaib A
    Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolytic therapy for acute ischaemic stroke: successful implementation in an Australian tertiary hospital.
    Bray JE; Coughlan K; Bladin C
    Intern Med J; 2006 Aug; 36(8):483-8. PubMed ID: 16866650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute ischemic stroke management: administration of thrombolytics, neuroprotectants, and general principles of medical management.
    Khaja AM
    Neurol Clin; 2008 Nov; 26(4):943-61, viii. PubMed ID: 19026898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuroprotection in brain ischemia--doubts and hopes].
    Zádor Z; Benyó Z; Lacza Z; Hortobágyi T; Harkány T; Hortobágyi T
    Ideggyogy Sz; 2004 Mar; 57(3-4):81-93. PubMed ID: 15133909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trafermin for stroke recovery: is it time for another randomized clinical trial?
    Paciaroni M; Bogousslavsky J
    Expert Opin Biol Ther; 2011 Nov; 11(11):1533-41. PubMed ID: 21883031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroprotective agents].
    Dávalos A
    Neurologia; 1999; 14 Suppl 4():49-53. PubMed ID: 10613033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An update of neuroprotectants in clinical development for acute stroke.
    Lutsep H; Clark W
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1732-6. PubMed ID: 11892936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral protection, brain repair, plasticity and cell therapy in ischemic stroke.
    Gutiérrez M; Merino JJ; Alonso de Leciñana M; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():177-86. PubMed ID: 19342849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel approaches to neuroprotection trials in acute ischemic stroke.
    Tymianski M
    Stroke; 2013 Oct; 44(10):2942-50. PubMed ID: 24021680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.